Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks - Concepedia

Concepedia

Publication | Closed Access

Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks

34

Citations

17

References

2010

Year

Roberto Zajdenverg, Thomas Podsadecki, Sharlaa Badal‐Faesen, Jaime Andrade‐Villanueva, Joseph Gathe, Horacio Mingrone, Linda Fredrick, I. Gaultier, William C. Woodward, Barry Bernstein

JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

LPV/r dosed QD resulted in increased treatment adherence and was as efficacious as BID LPV/r while providing similar safety, tolerability, and limited resistance evolution.

References

	Year	Citations

Page 1